secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVANTA INC (NOVT)
CIK:        0001076930
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0000950170-25-026854
Event type: other
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Novanta recasts segment reporting into Automation Enabling Technologies and Medical Solutions
--------------------------------------------------------------------------------

- Two new segments replace prior three-segment structure (Precision Medicine & Manufacturing, Robotics & Automation, Medical Solutions).
- Automation Enabling Technologies FY2024 revenue $490.6M, operating income $106.4M (up 10.5% YoY).
- Medical Solutions FY2024 revenue $458.6M (up 19.9% YoY), operating income $57.5M (down 9.1% YoY).
- Total FY2024 revenue $949.2M, operating income $110.6M; gross margin 44.4% vs 45.4% in FY2023.
- Q4 2024 Medical Solutions operating income dropped to $7.0M from $15.8M a year earlier.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1076930/000095017025026854/0000950170-25-026854-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1076930/000095017025026854/novt-20250225.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-026854

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer